$CPRX insider trading
Over the last 12 months, Catalyst Pharmaceuticals insiders reported no purchases and 13 sales totaling $212.8M across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $212.8M 13 events
- Events · 12m
- 13 Form 4 filings, grouped
- Insiders · 12m
- 13 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Elsbernd BrianChief Legal Officer · O | ▽ Sale to issuer | 242,501 | $31.5 | $7.6M | -100% | — |
| Jul 15, 2026 | Tierney David SD | ▽ Sale to issuer | 383,314 | $31.5 | $12.1M | -100% | — |
| Jul 15, 2026 | Miller SteveChief Op. & Scientific Officer · O | ▽ Sale to issuer | 1,093,803 | $31.5 | $34.5M | -100% | — |
| Jul 15, 2026 | Thompson TamarD | ▽ Sale to issuer | 3,773 | $31.5 | $119K | -100% | — |
| Jul 15, 2026 | Russo GreggChief HR Officer · O | ▽ Sale to issuer | 476 | $31.5 | $15K | -100% | — |
| Jul 15, 2026 | MCENANY PATRICK JD | ▽ Sale to issuer | 4,171,559 | $31.5 | $131.4M | -100% | — |
| Jul 15, 2026 | DENKHAUS DONALD AD | ▽ Sale to issuer | 498,773 | $31.5 | $15.7M | -100% | — |
| Jul 15, 2026 | Del Carmen JeffreyChief Commercial Officer · O | ▽ Sale to issuer | 14,337 | $31.5 | $452K | -100% | — |
| Jul 15, 2026 | Sundaram PreethiChief Strategy Officer · O | ▽ Sale to issuer | 54,804 | $31.5 | $1.7M | -100% | — |
| Jul 15, 2026 | Daly Richard JPresident and CEO · O·D | ▽ Sale to issuer | 271,266 | $31.5 | $8.5M | -100% | — |
| Jul 15, 2026 | Andrews William T.Chief Medical Officer · O | ▽ Sale to issuer | 2,309 | $31.5 | $73K | -100% | — |
| Jul 15, 2026 | Harper MollyD | ▽ Sale to issuer | 3,694 | $31.5 | $116K | -100% | — |
| Jul 15, 2026 | Kalb Michael WayneChief Financial Officer · O | ▽ Sale to issuer | 13,665 | $31.5 | $430K | -100% | — |
Every $CPRX filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Catalyst Pharmaceuticals filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CPRX feed.